Inactive Instrument

Naturecell Co Ltd Stock Korea S.E.

Equities

Pharmaceuticals

End-of-day quote Korea S.E.
- - Intraday chart for Naturecell Co Ltd

Financials

Sales 2022 21.55B 15.61M 0 21.34M Sales 2023 19.35B 14.01M 0 19.16M Capitalization 513B 371M 0 507M
Net income 2022 -6.81B -4.93M - -6.75M Net income 2023 -11.68B -8.46M - -11.56M EV / Sales 2022 44.1 x
Net cash position 2022 5.72B 4.14M 0 5.67M Net cash position 2023 27.58B 19.97M 0 27.3M EV / Sales 2023 25.1 x
P/E ratio 2022
-140 x
P/E ratio 2023
-43.5 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 80.05%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 59 16-01-28
President 51 20-03-25
President 61 13-08-15
Members of the board TitleAgeSince
Chief Executive Officer 59 16-01-28
President 61 13-08-15
President 51 20-03-25
More insiders
NatureCell Co Ltd is a Korea-based company principally engaged in the stem cell business. The Company operates its business through three segments. The Stem Cell Business segment is engaged in the development of stem cell therapeutics, the manufacture of stem cell culture media, the development and sale of stem cell culture cosmetics, and the provision of blood cell storage services, among others. The Food Business segment is engaged in the manufacture and sale of fruit beverages including tomato juice, peach juice and others, canned beverages such as sikhye, fruit concentrates and others, as well as fermentation and health functional foods. The Hygiene Business segment is engaged in the manufacture and sale of health hygiene products such as masks, disinfectants, wipes, and others.
More about the company